1. Sufentanil Protects the Liver from Ischemia/Reperfusion-Induced Inflammation and Apoptosis by Inhibiting ATF4-Induced TP53BP2 Expression.
    Ling Zhou et al, 2021, Inflammation CrossRef
  2. Sufentanil inhibits the proliferation and epithelial mesenchymal transition of lung cancer cells through Wnt/beta-catenin signaling pathway
    Minghan Guan et al, 2022, Bioengineered CrossRef
  3. Effects of Dexmedetomidine on Immune Cells: A Narrative Review
    Rui Chen et al, 2022, Front. Pharmacol. CrossRef
  4. Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
    Yingping Jia et al, 2022, Front. Pharmacol. CrossRef
  5. Effect of dexmedetomidine on postoperative systemic inflammation and recovery in patients undergoing digest tract cancer surgery: A meta-analysis of randomized controlled trials
    Wenjie Xu et al, 2022, Front. Oncol. CrossRef
  6. Dexmedetomidine promotes autophagy and apoptosis of colon cancer cells by activating endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4 signaling pathway
    Xiaochao Hou et al, 2023, Mol. Cell. Toxicol. CrossRef
  7. Sufentanil inhibits Pin1 to attenuate renal tubular epithelial cell ischemia–reperfusion injury by activating the PI3K/AKT/FOXO1 pathway
    Chunhui Liu et al, 2023, Int Urol Nephrol CrossRef
  8. Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-κB pathway
    Mingming Li et al, 2023, Immunopharmacology and Immunotoxicology CrossRef
  9. Trial watch: dexmedetomidine in cancer therapy
    Killian Carnet Le Provost et al, 2024, OncoImmunology CrossRef
  10. Bicentric lesion of colon cancer with postoperative fever: A case report
    Mengyuan Wang et al, 2024, Oncol Lett CrossRef
  11. Anti-Nociceptive Effect of Sufentanil Polymeric Dissolving Microneedle on Male Mice by Hot Plate Technique
    Zeinab Pourmansouri et al, 2024, IBJ CrossRef
  12. Immunomodulatory potential of dexmedetomidine in perioperative pain management for patients with cancer
    Yuxian Liu et al, 2025, Cancer Pathogenesis and Therapy CrossRef